Literature DB >> 14597715

The inhibitory potential of Fc receptor homolog 4 on memory B cells.

Gotz R A Ehrhardt1, Randall S Davis, Joyce T Hsu, Chuen-Miin Leu, Annette Ehrhardt, Max D Cooper.   

Abstract

Fc receptor homolog 4 (FcRH4) is a B cell-specific member of the recently identified family of FcRHs whose intracellular domain contains three potential immunoreceptor tyrosine-based inhibitory motifs (ITIMs). The signaling potential of this receptor, shown here to be preferentially expressed by memory B cells, was compared with the inhibitory receptor FcgammaRIIb in B cells expressing either WT FcgammaRIIb or chimeric proteins in which the intracellular domain of FcRH4 was fused to the transmembrane and extracellular domains of FcgammaRIIb. Coligation of the FcgammaRIIb/FcRH4 chimeric protein with the B cell receptor (BCR) led to tyrosine phosphorylation of the two membrane-distal tyrosines and profound inhibition of BCR-mediated calcium mobilization, whole cell tyrosine phosphorylation, and mitogen-activated protein (MAP)-kinase activation. Mutational analysis of the FcRH4 cytoplasmic region indicated that the two membrane-distal ITIMs are essential for this inhibitory potential. Phosphopeptides corresponding to these ITIMs could bind the Src homology 2 (SH2) domain-containing tyrosine phosphatases SHP-1 and SHP-2, which associated with the WT FcRH4 and with mutants having inhibitory capability. These findings indicate the potential for FcRH4 to abort B cell receptor signaling by recruiting SHP-1 and SHP-2 to its two membrane distal ITIMs.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14597715      PMCID: PMC263841          DOI: 10.1073/pnas.1935944100

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  29 in total

1.  The RasGAP-binding protein p62dok is a mediator of inhibitory FcgammaRIIB signals in B cells.

Authors:  I Tamir; J C Stolpa; C D Helgason; K Nakamura; P Bruhns; M Daeron; J C Cambier
Journal:  Immunity       Date:  2000-03       Impact factor: 31.745

2.  Enhanced genome annotation using structural profiles in the program 3D-PSSM.

Authors:  L A Kelley; R M MacCallum; M J Sternberg
Journal:  J Mol Biol       Date:  2000-06-02       Impact factor: 5.469

3.  The 145-kDa protein induced to associate with Shc by multiple cytokines is an inositol tetraphosphate and phosphatidylinositol 3,4,5-triphosphate 5-phosphatase.

Authors:  J E Damen; L Liu; P Rosten; R K Humphries; A B Jefferson; P W Majerus; G Krystal
Journal:  Proc Natl Acad Sci U S A       Date:  1996-02-20       Impact factor: 11.205

4.  Deletion of SHIP or SHP-1 reveals two distinct pathways for inhibitory signaling.

Authors:  M Ono; H Okada; S Bolland; S Yanagi; T Kurosaki; J V Ravetch
Journal:  Cell       Date:  1997-07-25       Impact factor: 41.582

5.  Role of the rasGAP-associated docking protein p62(dok) in negative regulation of B cell receptor-mediated signaling.

Authors:  Y Yamanashi; T Tamura; T Kanamori; H Yamane; H Nariuchi; T Yamamoto; D Baltimore
Journal:  Genes Dev       Date:  2000-01-01       Impact factor: 11.361

6.  M-Ras, a widely expressed 29-kD homologue of p21 Ras: expression of a constitutively active mutant results in factor-independent growth of an interleukin-3-dependent cell line.

Authors:  G R Ehrhardt; K B Leslie; F Lee; J S Wieler; J W Schrader
Journal:  Blood       Date:  1999-10-01       Impact factor: 22.113

7.  Spontaneous autoimmune disease in Fc(gamma)RIIB-deficient mice results from strain-specific epistasis.

Authors:  S Bolland; J V Ravetch
Journal:  Immunity       Date:  2000-08       Impact factor: 31.745

8.  Role of the inositol phosphatase SHIP in negative regulation of the immune system by the receptor Fc(gamma)RIIB.

Authors:  M Ono; S Bolland; P Tempst; J V Ravetch
Journal:  Nature       Date:  1996-09-19       Impact factor: 49.962

9.  Analysis of somatic mutation in five B cell subsets of human tonsil.

Authors:  V Pascual; Y J Liu; A Magalski; O de Bouteiller; J Banchereau; J D Capra
Journal:  J Exp Med       Date:  1994-07-01       Impact factor: 14.307

10.  Differential regulation of B cell development, activation, and death by the src homology 2 domain-containing 5' inositol phosphatase (SHIP).

Authors:  A Brauweiler; I Tamir; J Dal Porto; R J Benschop; C D Helgason; R K Humphries; J H Freed; J C Cambier
Journal:  J Exp Med       Date:  2000-05-01       Impact factor: 14.307

View more
  55 in total

1.  Attenuation of HIV-associated human B cell exhaustion by siRNA downregulation of inhibitory receptors.

Authors:  Lela Kardava; Susan Moir; Wei Wang; Jason Ho; Clarisa M Buckner; Jacqueline G Posada; Marie A O'Shea; Gregg Roby; Jenny Chen; Hae Won Sohn; Tae-Wook Chun; Susan K Pierce; Anthony S Fauci
Journal:  J Clin Invest       Date:  2011-07       Impact factor: 14.808

2.  Clonal B cells in patients with hepatitis C virus-associated mixed cryoglobulinemia contain an expanded anergic CD21low B-cell subset.

Authors:  Edgar D Charles; Claudia Brunetti; Svetlana Marukian; Kimberly D Ritola; Andrew H Talal; Kristen Marks; Ira M Jacobson; Charles M Rice; Lynn B Dustin
Journal:  Blood       Date:  2011-03-18       Impact factor: 22.113

3.  Antibodies Encoded by FCRL4-Bearing Memory B Cells Preferentially Recognize Commensal Microbial Antigens.

Authors:  Yanling Liu; Jonathan R McDaniel; Srijit Khan; Paolo Campisi; Evan J Propst; Theresa Holler; Eyal Grunebaum; George Georgiou; Gregory C Ippolito; Götz R A Ehrhardt
Journal:  J Immunol       Date:  2018-04-27       Impact factor: 5.422

4.  Tumor-specific MHC-II expression drives a unique pattern of resistance to immunotherapy via LAG-3/FCRL6 engagement.

Authors:  Douglas B Johnson; Mellissa J Nixon; Yu Wang; Daniel Y Wang; Emily Castellanos; Monica V Estrada; Paula I Ericsson-Gonzalez; Candace H Cote; Roberto Salgado; Violeta Sanchez; Phillip T Dean; Susan R Opalenik; Daniel M Schreeder; David L Rimm; Ju Young Kim; Jennifer Bordeaux; Sherene Loi; Leora Horn; Melinda E Sanders; P Brent Ferrell; Yaomin Xu; Jeffrey A Sosman; Randall S Davis; Justin M Balko
Journal:  JCI Insight       Date:  2018-12-20

5.  Involvement of the HCK and FGR src-family kinases in FCRL4-mediated immune regulation.

Authors:  Yanling Liu; Ksenia Bezverbnaya; Tiantian Zhao; Marion J Parsons; Mengyao Shi; Bebhinn Treanor; Götz R A Ehrhardt
Journal:  J Immunol       Date:  2015-05-13       Impact factor: 5.422

6.  Ancient divergence of a complex family of immune-type receptor genes.

Authors:  John P Cannon; Robert N Haire; M Gail Mueller; Ronda T Litman; Donna D Eason; Deborah Tinnemore; Chris T Amemiya; Tatsuya Ota; Gary W Litman
Journal:  Immunogenetics       Date:  2006-04-26       Impact factor: 2.846

7.  FCRL6 distinguishes mature cytotoxic lymphocytes and is upregulated in patients with B-cell chronic lymphocytic leukemia.

Authors:  Daniel M Schreeder; Jicun Pan; Fu Jun Li; Eric Vivier; Randall S Davis
Journal:  Eur J Immunol       Date:  2008-11       Impact factor: 5.532

8.  Investigation of the human FCRL1, 2, and 4 gene expressions in patients with rheumatoid arthritis.

Authors:  Ali Khanzadeh; Zahra Habibagahi; Ahmad Hosseini; Zahra Amirghofran
Journal:  Rheumatol Int       Date:  2016-05-18       Impact factor: 2.631

9.  Human Fc receptor-like 5 binds intact IgG via mechanisms distinct from those of Fc receptors.

Authors:  Andrea Franco; Bazarragchaa Damdinsuren; Tomoko Ise; Jessica Dement-Brown; Huifang Li; Satoshi Nagata; Mate Tolnay
Journal:  J Immunol       Date:  2013-04-24       Impact factor: 5.422

Review 10.  The human intestinal B-cell response.

Authors:  J Spencer; L M Sollid
Journal:  Mucosal Immunol       Date:  2016-07-27       Impact factor: 7.313

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.